Our President/CEO offers a management plan for health care providers when patients inquire about their direct-to-consumer genetic testing results.
Recent Posts
- Looking Back on the 10-year Anniversary of the SCOTUS Decision
- Genetic Testing Challenges in Oncology: Karyotype, Germline Clues in Somatic Diagnosis Lost in Translation
- Genetic Testing Challenges in Oncology: Patient with Pending Bill has BRCA1 Result Withheld
- Precision Oncology in 2022: New Drugs and Tests Amid Ongoing Access Barriers
- NSGC 2022 Poster Presentation